The TBE Book: 2nd Edition

Pirmais vāks
Prof. Dr. Gerhard Dobler, Dr. Wilhelm Erber, Dr. Michael Bröker, Prof. Dr. Heinz-Josef Schmit
Global Health Press, 2019. gada 15. apr. - 470 lappuses

While the number of vector-borne diseases and their incidence in Europe is much less than in tropical and/or developing countries, there are nevertheless a substantial number of such infections in Europe. The most important one is the zoonotic arbovirus infection Tick-Borne Encephalitis (TBE), a virus transmitted to humans by ticks or by consumption of unpasteurized dairy products from infected cows, goats, or sheep.


TBE is endemic in the non-tropical Eurasian forest belt with most cases occurring in Russia and in central and eastern parts of Europe. In endemic areas, TBE is one of the most important causes of viral meningitis/encephalitis and a major public health concern. Moreover, TBE is becoming more and more frequent in Europe due to the appearance of new endemic areas and increasing awareness.


However, it might be difficult to diagnose TBE, because clinical manifestations tend to be relatively nonspecific. Although a standardized case definition across the European Union has existed now for a few years, national implementation of TBE programs, including regular screening and diagnosis, are done in only very few countries. Therefore, wide differences in the intensity and quality of national surveillance of TBE cases still exist, and the true burden of disease and the areas with circulation of the TBE viral subtypes in Europe and Asia are not fully known. Moreover, although safe and effective vaccines are available, vaccination uptake in most endemic countries is too low to reduce the TBE burden significantly. 


The authors of “The TBE Book’ therefore have tried to compile in this “working book” the most recent and relevant aspects of TBE. 

 

Lietotāju komentāri - Rakstīt atsauksmi

Ierastajās vietās neesam atraduši nevienu atsauksmi.

Atlasītās lappuses

Saturs

1
2a
2b
3
4
5
6
7
12b_Germany
12b_Hungary
12b_Italy
12b_Japan
12b_Kazakhstan
12b_Kyrgyzstan
12b_Latvia
12b_Lithuania

8
9
10
11
12a
12b
12b_Austria
12b_Belarus
12b_Belgium
12b_Bosnia and Herzegovina
12b_Bulgaria
12b_China
12b_Croatia
12b_Czech Republic
12b_Denmark
12b_Estonia
12b_Finland
12b_France
12b_Moldova
12b_Mongolia
12b_Netherlands
12b_Norway
12b_Poland
12b_Romania
12b_Russia
12b_Serbia
12b_Slovakia
12b_Slovenia
12b_South Korea
12b_Sweden
12b_Switzerland and Liechtenstein
12b_Ukraine
12c
13
14
Autortiesības

Bieži izmantoti vārdi un frāzes

Par autoru (2019)

Bundeswehr Institute of Microbiology, Munich, Germany

Director Medical and Scientific Affairs, Pfizer Vaccines, Vienna, Austria

Editor, Global Health Press, Singapore / Marburg, Germany

Vice President, Global Lead Viral Vaccines and Clinical Affairs, Pfizer Vaccines, Collegeville, PA, USA Johannes Gutenberg University, Mainz, Germany 

Bibliogrāfiskā informācija